Decay-accelerating factor (CD55) and membrane inhibitor of reactive lysis (CD59) are released within exosomes during in vitro maturation of reticulocytes

被引:120
|
作者
Rabesandratana, H
Toutant, JP
Reggio, H
Vidal, M
机构
[1] Univ Montpellier 2, UMR 5539, F-34095 Montpellier, France
[2] Hop St Eloi, Cent Hematol Lab, Montpellier, France
[3] INRA, F-34060 Montpellier, France
关键词
D O I
10.1182/blood.V91.7.2573.2573_2573_2580
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Exosomes are membrane vesicles released by reticulocytes during their maturation into erythrocytes. They have a clearing function because of their enrichment with some proteins known to decrease or disappear from the cell surface during maturation, eg, acetylcholinesterase (AChE) and transferrin receptor (TIR), respectively. To better understand the molecular events leading to protein sorting in exosomes, we analyzed the expression of glycosylphosphatidylinositol (GPI)-anchored proteins on the exosome surface through a technique involving bead coupling and flow cytometry immunodetection. The presence of AChE, decay-accelerating factor (DAF), membrane inhibitor of reactive lysis (MIRL), and lymphocyte function-associated antigen 3 (LFA-3) on the surface of exosomes obtained from normal and paroxysmal nocturnal hemoglobinuria (PNH) reticulocytes, suggests that (1) the GPI anchor is efficiently sorted during exosome formation, (2) exosome release could account for the observed discrepancy in GPI-protein expression between reticulocytes and erythrocytes from PNH patients, and (3) exosomes could have another physiologic function related to controlling membrane attack complex formation. (C) 1998 by The American Society of Hematology.
引用
收藏
页码:2573 / 2580
页数:8
相关论文
共 50 条
  • [1] DIFFERENTIAL EXPRESSION OF COMPLEMENT REGULATORY PROTEINS DECAY-ACCELERATING FACTOR (CD55), MEMBRANE COFACTOR PROTEIN (CD46) AND CD59 DURING HUMAN SPERMATOGENESIS
    SIMPSON, KL
    HOLMES, CH
    IMMUNOLOGY, 1994, 81 (03) : 452 - 461
  • [2] CRYSTALLOGRAPHIC STUDIES OF DECAY-ACCELERATING FACTOR (CD55)
    Lukacik, P.
    Billington, J.
    Heinrich, A.
    Thurston, K.
    Smith, G.
    White, J.
    Smith, R. A.
    Lea, S. M.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2002, 58 : C281 - C281
  • [3] STRUCTURE AND FUNCTION OF DECAY-ACCELERATING FACTOR CD55
    NICHOLSONWELLER, A
    WANG, C
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1994, 123 (04): : 485 - 491
  • [4] Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin)
    Niehans, GA
    Cherwitz, DL
    Staley, NA
    Knapp, DJ
    Dalmasso, AP
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 149 (01): : 129 - 142
  • [5] Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor
    Martino, TA
    Peric, M
    Brown, M
    Aitken, K
    Gauntt, CJ
    Richardson, CD
    Chow, LH
    Liu, PP
    VIROLOGY, 1998, 244 (02) : 302 - 314
  • [6] Decay-accelerating factor (CD55) deficiency phenotypes in Japanese
    Daniels, GL
    Green, CA
    Mallinson, G
    Okubo, Y
    Hori, Y
    Kataoka, A
    Kaihara, M
    TRANSFUSION MEDICINE, 1998, 8 (02) : 141 - 147
  • [7] EFFECT OF TRANSFECTED MACIF (CD59) ON COMPLEMENT-MEDIATED SWINE ENDOTHELIAL-CELL LYSIS, COMPARED WITH THOSE OF MEMBRANE COFACTOR PROTEIN (CD46) AND DECAY-ACCELERATING FACTOR (CD55)
    MIYAGAWA, S
    SHIRAKURA, R
    NAKATA, S
    IZUTANI, H
    MATSUDA, H
    IWATA, K
    NAGASAWA, S
    TERADO, A
    HATANAKA, M
    MATSUMOTO, M
    SEYA, T
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (01) : 328 - 329
  • [8] TEST FOR ABILITY OF DECAY-ACCELERATING FACTOR (DAF, CD55) AND CD59 TO ALLEVIATE COMPLEMENT-MEDIATED DAMAGE OF XENO-ERYTHROCYTES
    MIYAGAWA, S
    SHIRAKURA, R
    MATSUMIYA, G
    NAKATA, S
    MATSUDA, H
    HATANAKA, M
    MATSUMOTO, M
    KITAMURA, H
    SEYA, T
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1993, 38 (01) : 37 - 44
  • [9] Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas
    Maenpaa, A
    Junnikkala, S
    Hakulinen, J
    Timonen, T
    Meri, S
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 148 (04): : 1139 - 1152
  • [10] Progesterone Receptors Signaling and Upregulation of Decay-Accelerating Factor (DAF/CD55)
    Ansley, Ariel J.
    Rana, Tanu
    Nowicki, Stella
    Nowicki, Bogdan
    OBSTETRICS AND GYNECOLOGY, 2014, 123 : 135S - 136S